Clinical Trial Update: Short-term Clinical Feasibility of the New Provox Vega 22.5 Voice Prosthesis [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update reports short-term feasibility of the Provox Vega 22.5 voice prosthesis for total laryngectomy across Phase 1 and Phase 2, with completed …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Total Laryngectomy

Drugs mentioned

• Provox Vega 22.5 voice prosthesis

Snippet

Sponsor: Atos Medical AB | Conditions: Total Laryngectomy | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2010-11-03